JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> Consumer Product Testing >> Media Centre >> News >> H1N1 - virucidal efficacy

Eurofins - reliable analyses for H1N1 Virucidal Efficacy

Sidebar Image

The Pandemic Swine Flu (H1N1 influenzavirus A) is currently of worldwide concern.

How Eurofins can support you:  

We make sure that the products you market are an efficient virucide against the H1N1infuenzavirus A, Eurofins is pleased to offer an internationally recognized reliable, cost effective and rapid test:-

Virucidal Activity - Phase2/Step1 QST test according to the European standard EN14476:2007

Application field

This European standard EN14476 is applicable to products for which disinfectant activity against viruses are claimed. It is applicable to products to be used for surface, skin or instrumental disinfection and chemical disinfectants and antiseptics to be used in areas and situations where disinfection is required. 

Such situations arise:

- in hospitals, in community medical facilities and dental institutions,
- in clinics of schools, of nurseries and of nursing homes
- in the workplace, in public areas and in the home.
- in services such as in laundries and kitchens supplying products. 

Efficacy Testing

Eurofins testing evaluates the capability of a disinfectant formulation or antimicrobial product to produce a reduction in the number of infecting viral particles on suitable human derived host cells. 

What is the H1N1 A virus?  

Influenza A(H1N1) virus is a subtype of influenzavirus A and the most common cause of influenza (flu) in humans. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a large fraction of allseasonal influenza. H1N1 strains caused roughly half of all human flu infections in 2006. Other strains of H1N1 are endemic in pigs (swine influenza) and in birds (avian influenza).In June 2009, WHO declared that flu due to a new strain of swine-origin H1N1 was responsible for the 2009 flu pandemic. It was originally referred to as "swine flu" because laboratory testing showed that many of the genes in this new virus were very similar to influenza viruses that normally occur in pigs in North America. However, further study has shown that this virus is made up of genetic elements from four different flu viruses: North American swine influenza, North American avian influenza, human influenza, and swine influenza virus typically found in Asia and Europe.

Knowing what steps to take to protect yourself, your loved ones, or your business can be confusing, especially with all the coverage in the media. The Department of Health's document Pandemic Flu - Guidance for Businesses advises people what precautions to take.

Contact an expert today to find out more: 
 

by phone: +44 161 868 7600 
by eMail: barryhilton@eurofins.co.uk